Generation Bio (GBIO)
(Real Time Quote from BATS)
$2.89 USD
-0.01 (-0.35%)
Updated Apr 29, 2024 03:33 PM ET
After-Market: $2.85 -0.04 (-1.38%) 4:08 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Brokerage Reports
0 items in cart
Generation Bio Co. [GBIO]
Reports for Purchase
Showing records 1 - 20 ( 42 total )
Company: Generation Bio Co.
Industry: Medical - Generic Drugs
Company: Generation Bio Co.
Industry: Medical - Generic Drugs
Company: Generation Bio Co.
Industry: Medical - Generic Drugs
Company: Generation Bio Co.
Industry: Medical - Generic Drugs
Out with the Old (ce), In with the New (iq)DNA
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Generation Bio Co.
Industry: Medical - Generic Drugs
Company: Generation Bio Co.
Industry: Medical - Generic Drugs
Potential Generational Shift in Genetic Medicines
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Generation Bio Co.
Industry: Medical - Generic Drugs
Company: Generation Bio Co.
Industry: Medical - Generic Drugs
Company: Generation Bio Co.
Industry: Medical - Generic Drugs
Company: Generation Bio Co.
Industry: Medical - Generic Drugs
Company: Generation Bio Co.
Industry: Medical - Generic Drugs
Moderna Deal Helps Get Closer to Proof of Concept
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Generation Bio Co.
Industry: Medical - Generic Drugs
Company: Generation Bio Co.
Industry: Medical - Generic Drugs
Company: Generation Bio Co.
Industry: Medical - Generic Drugs
Heading Into a New Generation with Two Novel ctLNPs
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D